Related references
Note: Only part of the references are listed.Replication and contradiction of highly cited research papers in psychiatry: 10-year follow-up
Aran Tajika et al.
BRITISH JOURNAL OF PSYCHIATRY (2015)
Negative symptoms and functioning during the first year after a recent onset of schizophrenia and 8 years later
Joseph Ventura et al.
SCHIZOPHRENIA RESEARCH (2015)
Treatment resistant schizophrenia: a comprehensive survey of randomised controlled trials
Diarmid Sinclair et al.
BMC PSYCHIATRY (2014)
Negative symptoms of schizophrenia: Clinical characteristics, pathophysiological substrates, experimental models and prospects for improved treatment
Mark J. Milian et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2014)
Augmentation strategies in partial responder and/or treatment-resistant schizophrenia patients treated with clozapine
Maria Rosaria A. Muscatello et al.
EXPERT OPINION ON PHARMACOTHERAPY (2014)
Clozapine Augmented with Glutamate Modulators in Refractory Schizophrenia: A Review and Metaanalysis
S. R. T. Veerman et al.
PHARMACOPSYCHIATRY (2014)
Non-Glutamatergic Clozapine Augmentation Strategies: A Review and Meta-Analysis
S. R. T. Veerman et al.
PHARMACOPSYCHIATRY (2014)
The Glutamate Hypothesis: A Pathogenic Pathway from which Pharmacological interventions have Emerged
S. R. T. Veerman et al.
PHARMACOPSYCHIATRY (2014)
被撤回的出版物: World Medical Association Declaration of Helsinki Ethical Principles for Medical Research Involving Human Subjects (Retracted article. See vol. 135, pg. 2149, 2021)
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2013)
Memantine Add-On to Risperidone for Treatment of Negative Symptoms in Patients With Stable Schizophrenia Randomized, Double-Blind, Placebo-Controlled Study
Farzin Rezaei et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2013)
Two subdomains of negative symptoms in psychotic disorders: Established and confirmed in two large cohorts
Edith Liemburg et al.
JOURNAL OF PSYCHIATRIC RESEARCH (2013)
Lamotrigine augmentation in patients with schizophrenia who show partial response to clozapine treatment
Sefa Vayisoglu et al.
SCHIZOPHRENIA RESEARCH (2013)
Clozapine, but not haloperidol, enhances glial d-serine and L-glutamate release in rat frontal cortex and primary cultured astrocytes
Shunske Tanahashi et al.
BRITISH JOURNAL OF PHARMACOLOGY (2012)
Adjunctive Memantine Therapy for Cognitive Impairment in Chronic Schizophrenia: A Placebo-Controlled Pilot Study
Jung Goo Lee et al.
PSYCHIATRY INVESTIGATION (2012)
World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Schizophrenia, Part 1: Update 2012 on the acute treatment of schizophrenia and the management of treatment resistance
Alkomiet Hasan et al.
WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY (2012)
Cognitive Control Deficits in Schizophrenia: Mechanisms and Meaning
Tyler A. Lesh et al.
NEUROPSYCHOPHARMACOLOGY (2011)
N-methyl-D-aspartate (NMDA) receptor dysfunction or dysregulation: The final common pathway on the road to schizophrenia?
Joshua T. Kantrowitz et al.
BRAIN RESEARCH BULLETIN (2010)
Assessing cognitive function in clinical trials of schizophrenia
Jennifer H. Barnett et al.
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2010)
Homeostatic regulation of glutamatergic transmission by dopamine D4 receptors
Eunice Y. Yuen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Improvement of Negative and Positive Symptoms in Treatment-Refractory Schizophrenia: A Double-Blind, Randomized, Placebo-Controlled Trial With Memantine as Add-On Therapy to Clozapine
David de Lucena et al.
JOURNAL OF CLINICAL PSYCHIATRY (2009)
Topiramate add-on treatment in schizophrenia: a randomised, double-blind, placebo-controlled clinical trial
H. Afshar et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2009)
A Randomized, Placebo-Controlled Study of Memantine as Adjunctive Treatment in Patients with Schizophrenia
Jeffrey A. Lieberman et al.
NEUROPSYCHOPHARMACOLOGY (2009)
The Dopamine Hypothesis of Schizophrenia: Version III - The Final Common Pathway
Oliver D. Howes et al.
SCHIZOPHRENIA BULLETIN (2009)
The MATRICS consensus cognitive battery, part 1: Test selection, reliability, and validity
Keith H. Nuechterlein et al.
AMERICAN JOURNAL OF PSYCHIATRY (2008)
Memantine for the treatment of Alzheimer's disease
Martin R. Farlow et al.
DRUG SAFETY (2008)
Lamotrigine as add-on therapy in schizophrenia - Results of 2 placebo-controlled trials
Donald C. Goff et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2007)
NMDA receptor hypofunction produces opposite effects on prefrontal cortex Interneurons and pyramidal neurons
Houman Homayoun et al.
JOURNAL OF NEUROSCIENCE (2007)
Coincident activation of metabotropic glutamate receptors and NMDA receptors (NMDARs) downregulates perisynaptic/extrasynaptic NMDARs and enhances high-fidelity neurotransmission at the developing calyx of held synapse
Indu Joshi et al.
JOURNAL OF NEUROSCIENCE (2007)
FACT: A Dutch version of ACT
J. Remmers van Veldhuizen
COMMUNITY MENTAL HEALTH JOURNAL (2007)
The effect of lamotrigine augmentation of clozapine in a sample of treatment-resistant schizophrenic patients:: A double-blind, placebo-controlled study
R. Zoccali et al.
SCHIZOPHRENIA RESEARCH (2007)
Glutamate and dopamine dysregulation in schizophrenia - A synthesis and selective review
James M. Stone et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2007)
Computerized assessment of cognition in schizophrenia: Promises and pitfalls of CANTAB
Marie-Noelle Levaux et al.
EUROPEAN PSYCHIATRY (2007)
Memantine in moderate to severe Alzheimer's disease: a meta-analysis of randomised clinical trials
Bengt Winblad et al.
DEMENTIA AND GERIATRIC COGNITIVE DISORDERS (2007)
Pharmacology of acetylcholinesterase inhibitors and N-methyl-D-aspartate receptors for combination therapy in the treatment of Alzheimer's disease
Hugo Geerts et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2006)
Contradicted and initially stronger effects in highly cited clinical research
JPA Ioannidis
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2005)
Remission in schizophrenia: Proposed criteria and rationale for consensus
NC Andreasen et al.
AMERICAN JOURNAL OF PSYCHIATRY (2005)
What is an adequate trial with clozapine? Therapeutic drug monitoring and time to response in treatment-refractory schizophrenia
PFJ Schulte
CLINICAL PHARMACOKINETICS (2003)
Imaging the glutamatergic system in vivo -: relevance to schizophrenia
RA Bressan et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE (2000)
Share Paper
